MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Tuesday, June 21, 2016

12:30pm-2:00pm
Effect of zonisamide on post-traumatic Holmes’ tremor

T. Jo, S. Sekimoto, G. Oyama, N. Izawa, S. Ueno, Y. Shimo, A. Nakajima, M. Nakajima, A. Umemura, H. Arai, N. Hattori (Tokyo, Japan)

Tremor  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Effects of Arachidonyl-2′-chloroethylamide (ACEA), a selective CB1 receptor agonist, in MPTP mouse model of Parkinson’s disease

M. Omidbeigi, S. Asaadi, A. Zali (Tehran, Islamic Republic of Iran)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Efficacy and safety of a L-dopa delivery and monitoring medical device

Y.G. Tirat-Gefen (Fairfax, VA, USA)

Technology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Elevated SNCA expression in CD45+ peripheral blood cells in patients with dementia with Lewy bodies

N. Nikolaev, B. Lu.A., P.A. Andoskin, A. Emelyanov, A.E. Kopytova, K.A. Senkevich, I.V. Milyukhina, S.N. Pchelina (Saint-Petersburg, Russia)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Elucidating mechanisms of endogenous disease protection resulting in reduced penetrance in PINK1 deficiency

M. Vos, C. Böhm, C. Klein (Lübeck, Germany)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Endoscopically-documented pharyngeal dystonia due to neuroleptic use without response to alcohol

J.P. Squires, W.L. Severt, M.J. Pitman (New York, NY, USA)

Drug-induced movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Enteric neurons reveal substantial in vivo mitochondrial changes in Parkinson’s disease

P.M.A. Antony, A.S. Baumuratov, M. Ostaszewski, F. He, L. Salamanca, L. Antunes, J. Weber, L. Longhino, P. Derkinderen, R. Balling, W. Koopman, N. Diederich (Belvaux, Luxembourg)

Pathophysiology
12:30pm-2:00pm
Epigenome-wide association study of Parkinson’s disease

B. Ritz, Y.H. Chuang, S. Horvath, Y. Bordelon, J. Bronstein (Los Angeles, CA, USA)

Genetics (PD and Non-PD)
12:30pm-2:00pm
ESCRT-0 dysfunction compromises autophagic degradation of protein aggregates and facilitates ER stress-mediated neurodegeneration via apoptotic and necroptotic pathways

T. Hasegawa, R. Oshima, K. Tamai, N. Sugeno, A. Kikuchi, J. Kobayashi, S. Yoshida, A. Takeda, N. Tanaka, M. Aoki (Sendai, Japan)

Pathophysiology (other movement disorders)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Essential tremor: Characterization according to their phenotypes and their association with Parkinsonian signs

J.S. Bestoso, L. Ciancaglini, C.V. Stefani, L.A. di Napoli, J.I. Rojas, D.J. Bauso, E. Cristiano (Caba, Argentina)

Tremor  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 48
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley